HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:


Category disruption

HealthInvestor Asia talks with Abel Ang, group chief executive officer of Accuron MedTech. Listen in for insights into his activities in the region and some investments he has been making in category disruptors.

Asia's aging population

HealthInvestor Asia talks with Jonathan Tan, director of the Asia Pacific Risk Centre for the Marsh & McLennan Companies in Singapore. Listen in for insights into the challenges of the aging population to Asia.

Healthcare market snapshot

HealthInvestor Asia talks with Saurabh Gupta, head of healthcare and consumer at Maybank Kim Eng in Singapore. Listen in for insights into the capital markets and healthcare.

Aged Care in China

HealthInvestor Asia talks with John Mortensen, regional director for healthcare and education, Greater China for real estate specialist JLL. Listen in for insights into aged care in China.

Don't miss a podcast. Subscribe to our feed using one of the below:

Podcast feed URL
Subscribe via iTunes - coming soon

HealthInvestor Asia twitter feed


Markets in Asia continued their rally today, though gains were capped by a poor performance on Wall Street last night and threats of possible US government shutdown. “A predictable air of caution has engulfed global equity markets as we approach the final bell for US budget showdown. But in the bigger scheme of things this case of hic-ups is likely to pass as quickly as it arrived,” said Stephen Innes, head of trading APAC at online multi-asset trader OANDA in Singapore. Attention instead was on yesterday’s Q4 growth figures from China yesterday which beat market expectations. “Almost two-thirds of growth now comes from consumption, which has replaced investment as the biggest growth driver for China,” explained Wei Li, senior economist, China, for Standard Chartered Bank. Even though most economists believe that a slowing housing market and tighter financial conditions are likely to weigh on growth in 2018, traders grabbed the good news and the Shanghai Composite was last seen up almost 0.40%. Elsewhere the Nikkei traded very slightly higher as the US dollar remained flat. A pullback in the price of oil saw the commodity-heavy ASX trade down 0.15%.



The Future of Healthcare in Asia

Round table

Download the round table here

HealthInvestor UK